Shih-Cheng Yang
Overview
Explore the profile of Shih-Cheng Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ku H, Yang S, Hsiao H, Chen J, Ling M
Foods
. 2025 Feb;
14(3).
PMID: 39941958
In recent years, due to the rapid pace of urbanization and increasingly hectic modern lifestyles that leave little time for home cooking, more and more people prefer to dine at...
2.
Tai W, Wu I, Wang H, Huang P, Yao C, Wu C, et al.
J Microbiol Immunol Infect
. 2024 Mar;
57(4):601-608.
PMID: 38461114
Background: High-dose dual therapy (HDDT) using proton-pump inhibitors (PPI) and amoxicillin attracted attention for its simplicity and lower adverse event profile. Besides, vonoprazan is not available worldwide. This real-world study...
3.
Wang H, Huang P, Yang S, Wu M, Tai W, Chen C, et al.
Life (Basel)
. 2023 Sep;
13(9).
PMID: 37763266
Background: Gastroesophageal reflux disease (GERD) affects a significant proportion of individuals, with life stress being a contributing factor. This study aimed to investigate the correlation between psychosomatic evaluations, heart rate...
4.
Liu A, Tai W, Chiu S, Sou F, Yang S, Lu L, et al.
Infect Drug Resist
. 2023 Sep;
16:6167-6174.
PMID: 37724089
Background: Endoscopic Retrograde Cholangiopancreatography (ERCP), used for choledocholithiasis treatment, carries a risk of pyogenic liver abscess (PLA) due to communication between the biliary system and bowel contents. However, limited data...
5.
Tai W, Yang S, Yao C, Wu C, Liu A, Lee C, et al.
Infect Dis Ther
. 2023 May;
12(5):1415-1427.
PMID: 37133673
Introduction: High-dose dual therapy (HDDT) can attain acceptable eradication rates provided that the optimal doses, timing and treatment duration are applied. The existing evidence still shows inconsistent reports (< 90%)...
6.
Huang T, Yang S, Tai W, Liang C, Kuo C, Yao C, et al.
Biomed J
. 2022 Mar;
44(6 Suppl 2):S275-S281.
PMID: 35292265
Background: Non-bismuth containing quadruple therapy (concomitant therapy) is an alternative treatment for Helicobacter pylori (H. pylori) eradication with increasing clarithromycin-resistant strains over times. This study compared the efficacies of non-bismuth...
7.
Wu C, Hsu C, Cho W, Yang S, Liu A, Tai W, et al.
Infect Drug Resist
. 2021 Jun;
14:2121-2131.
PMID: 34135602
Background And Aim: Endoscopic sphincterotomy (ES) abolished the barrier between the hepatobiliary system and duodenum and might be at risk of pyogenic liver abscess (PLA). We aimed to identify the...
8.
Hung K, Yang S, Wu C, Wang H, Yao C, Liang C, et al.
Infect Drug Resist
. 2021 Apr;
14:1239-1246.
PMID: 33790594
Purpose: Non-bismuth concomitant quadruple therapy is commonly administered in Taiwan, achieving an acceptable efficacy as a first-line anti treatment. This study compared the eradication rates between esomeprazole- and lansoprazole-based non-bismuth...
9.
Tai C, Hsu C, Yang S, Wu C, Liang C, Tai W, et al.
Sci Rep
. 2020 Dec;
10(1):21329.
PMID: 33288865
In this study, we aimed to investigate the impact of aspirin on the risk of pyogenic liver abscess caused by Klebsiella pneumoniae (KP-PLA) and invasive KP-PLA syndrome (IKPS) in diabetic...
10.
Yang S, Wu C, Tai W, Liang C, Yao C, Wu K, et al.
J Gastroenterol Hepatol
. 2020 Nov;
36(7):1828-1835.
PMID: 33247982
Background And Aim: Clopidogrel is widely prescribed for patients with of aspirin-related upper gastrointestinal bleeding (UGIB) history. This study aimed to compare the risk of a major adverse cardiovascular event...